Global Self-Monitoring Blood Glucose System Market By Product Type (Blood Glucose meters, Testing strips) And By End-Users/Application (Type 2 Diabetes, Type 1 Diabetes) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Self-Monitoring Blood Glucose System market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Self-Monitoring Blood Glucose System market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Self-Monitoring Blood Glucose System industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Self-Monitoring Blood Glucose System ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Self-Monitoring Blood Glucose System market.

The following manufacturers are covered in this report:
  • Roche (Switzerland)
  • Abbott (US)
  • LifeScan (US)
  • Ascensia (Switzerland)
  • Medtronic (Ireland), Dexcom (US)
  • Ypsomed (Switzerland)
  • B. Braun (Germany)
  • Nipro (Japan), Sanofi (France)
  • ARKRAY (Japan)
  • Prodigy Diabetes Care (US)
  • ACON Laboratories (US)
  • Nova Biomedical (US)

The report estimates on the Self-Monitoring Blood Glucose System market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Self-Monitoring Blood Glucose System market report consist of all leading industry players, Self-Monitoring Blood Glucose System business sections, company profile, revenue supply by Self-Monitoring Blood Glucose System industry sections, global Self-Monitoring Blood Glucose System market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Self-Monitoring Blood Glucose System market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Self-Monitoring Blood Glucose System market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Self-Monitoring Blood Glucose System market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Self-Monitoring Blood Glucose System market.

Report Opportunity: Global Self-Monitoring Blood Glucose System Market

This report delivers an analytical examination of the Self-Monitoring Blood Glucose System market summarized in broad sections such as
  1. Self-Monitoring Blood Glucose System Market Summary
  2. Key Commercial Growths in the Self-Monitoring Blood Glucose System Industry
  3. Market Dynamics Affecting the Self-Monitoring Blood Glucose System Industry
  4. Important Market Trends and Future Development Scenario of the Self-Monitoring Blood Glucose System Market
  5. Self-Monitoring Blood Glucose System Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Self-Monitoring Blood Glucose System Industry
  7. Positioning of Main Market Players in the Self-Monitoring Blood Glucose System Industry
  8. Self-Monitoring Blood Glucose System Market Revenue and Forecast, by Application, 2018 - 2028
  9. Self-Monitoring Blood Glucose System Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Self-Monitoring Blood Glucose System Market Revenue and Forecast, by Geography, 2018 - 2028
Self-Monitoring Blood Glucose System Market Segmentation:

The report provides detailed examination of the Self-Monitoring Blood Glucose System market on the basis of various segments such as type, application and end-use industry. The Self-Monitoring Blood Glucose System market is segmented as follows:

Self-Monitoring Blood Glucose System Market, by Type:
  • Blood Glucose meters
  • Testing strips
  • Lancets & Lancing Devices
Self-Monitoring Blood Glucose System Market, by Application:
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Gestational Diabetes
Geographic Coverage

The report on the Self-Monitoring Blood Glucose System market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Self-Monitoring Blood Glucose System Market Revenue and Forecast
  • U.S.
  • Canada
Europe Self-Monitoring Blood Glucose System Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Self-Monitoring Blood Glucose System Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Self-Monitoring Blood Glucose System Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Self-Monitoring Blood Glucose System Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Self-Monitoring Blood Glucose System Market Snapshot
          2.1.1. Global Self-Monitoring Blood Glucose System Market By Type,2019
               2.1.1.1.Blood Glucose meters
               2.1.1.2.Testing strips
               2.1.1.3.Lancets & Lancing Devices
          2.1.2. Global Self-Monitoring Blood Glucose System Market By Application,2019
               2.1.2.1.Type 2 Diabetes
               2.1.2.2.Type 1 Diabetes
               2.1.2.3.Gestational Diabetes
          2.1.3. Global Self-Monitoring Blood Glucose System Market By End-use,2019
          2.1.4. Global Self-Monitoring Blood Glucose System Market By Geography,2019

3. Global Self-Monitoring Blood Glucose System Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028

5. Global Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028

6. Global Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028

7. Global Self-Monitoring Blood Glucose System Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Self-Monitoring Blood Glucose System Market Analysis, 2018 – 2028 
          7.2.1. North America Self-Monitoring Blood Glucose System Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Self-Monitoring Blood Glucose System Market Analysis, 2018 – 2028 
          7.3.1.  Europe Self-Monitoring Blood Glucose System Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Self-Monitoring Blood Glucose System Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Self-Monitoring Blood Glucose System Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Self-Monitoring Blood Glucose System Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Self-Monitoring Blood Glucose System Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Self-Monitoring Blood Glucose System Market Analysis, 2018 – 2028 
          7.6.1.  MEA Self-Monitoring Blood Glucose System Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Self-Monitoring Blood Glucose System Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Self-Monitoring Blood Glucose System Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Self-Monitoring Blood Glucose System Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Self-Monitoring Blood Glucose System Providers
        8.4.1 Roche (Switzerland)
                8.1.1 Business Description
                8.1.2 Roche (Switzerland) Geographic Operations
                8.1.3 Roche (Switzerland) Financial Information
                8.1.4 Roche (Switzerland) Product Positions/Portfolio
                8.1.5 Roche (Switzerland) Key Developments
        8.4.2 Abbott (US)
                8.2.1 Business Description
                8.2.2 Abbott (US) Geographic Operations
                8.2.3 Abbott (US) Financial Information
                8.2.4 Abbott (US) Product Positions/Portfolio
                8.2.5 Abbott (US) Key Developments
        8.4.3 LifeScan (US)
                8.3.1 Business Description
                8.3.2 LifeScan (US) Geographic Operations
                8.3.3 LifeScan (US) Financial Information
                8.3.4 LifeScan (US) Product Positions/Portfolio
                8.3.5 LifeScan (US) Key Developments
        8.4.4 Ascensia (Switzerland)
                8.4.1 Business Description
                8.4.2 Ascensia (Switzerland) Geographic Operations
                8.4.3 Ascensia (Switzerland) Financial Information
                8.4.4 Ascensia (Switzerland) Product Positions/Portfolio
                8.4.5 Ascensia (Switzerland) Key Developments
        8.4.5 Medtronic (Ireland), Dexcom (US)
                8.5.1 Business Description
                8.5.2 Medtronic (Ireland), Dexcom (US) Geographic Operations
                8.5.3 Medtronic (Ireland), Dexcom (US) Financial Information
                8.5.4 Medtronic (Ireland), Dexcom (US) Product Positions/Portfolio
                8.5.5 Medtronic (Ireland), Dexcom (US) Key Developments
        8.4.6 Ypsomed (Switzerland)
                8.6.1 Business Description
                8.6.2 Ypsomed (Switzerland) Geographic Operations
                8.6.3 Ypsomed (Switzerland) Financial Information
                8.6.4 Ypsomed (Switzerland) Product Positions/Portfolio
                8.6.5 Ypsomed (Switzerland) Key Developments
        8.4.7 B. Braun (Germany)
                8.7.1 Business Description
                8.7.2 B. Braun (Germany) Geographic Operations
                8.7.3 B. Braun (Germany) Financial Information
                8.7.4 B. Braun (Germany) Product Positions/Portfolio
                8.7.5 B. Braun (Germany) Key Developments
        8.4.8 Nipro (Japan), Sanofi (France)
                8.8.1 Business Description
                8.8.2 Nipro (Japan), Sanofi (France) Geographic Operations
                8.8.3 Nipro (Japan), Sanofi (France) Financial Information
                8.8.4 Nipro (Japan), Sanofi (France) Product Positions/Portfolio
                8.8.5 Nipro (Japan), Sanofi (France) Key Developments
        8.4.9 ARKRAY (Japan)
                8.9.1 Business Description
                8.9.2 ARKRAY (Japan) Geographic Operations
                8.9.3 ARKRAY (Japan) Financial Information
                8.9.4 ARKRAY (Japan) Product Positions/Portfolio
                8.9.5 ARKRAY (Japan) Key Developments
        8.4.10 Prodigy Diabetes Care (US)
                8.10.1 Business Description
                8.10.2 Prodigy Diabetes Care (US) Geographic Operations
                8.10.3 Prodigy Diabetes Care (US) Financial Information
                8.10.4 Prodigy Diabetes Care (US) Product Positions/Portfolio
                8.10.5 Prodigy Diabetes Care (US) Key Developments
        8.4.11 ACON Laboratories (US)
                8.11.1 Business Description
                8.11.2 ACON Laboratories (US) Geographic Operations
                8.11.3 ACON Laboratories (US) Financial Information
                8.11.4 ACON Laboratories (US) Product Positions/Portfolio
                8.11.5 ACON Laboratories (US) Key Developments
        8.4.12 Nova Biomedical (US)
                8.12.1 Business Description
                8.12.2 Nova Biomedical (US) Geographic Operations
                8.12.3 Nova Biomedical (US) Financial Information
                8.12.4 Nova Biomedical (US) Product Positions/Portfolio
                8.12.5 Nova Biomedical (US) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Self-Monitoring Blood Glucose System Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Self-Monitoring Blood Glucose System Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Self-Monitoring Blood Glucose System Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Self-Monitoring Blood Glucose System Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Self-Monitoring Blood Glucose System Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Self-Monitoring Blood Glucose System Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Self-Monitoring Blood Glucose System Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Self-Monitoring Blood Glucose System Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Self-Monitoring Blood Glucose System Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Self-Monitoring Blood Glucose System Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Self-Monitoring Blood Glucose System Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Self-Monitoring Blood Glucose System Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Self-Monitoring Blood Glucose System Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Self-Monitoring Blood Glucose System Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Self-Monitoring Blood Glucose System Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Self-Monitoring Blood Glucose System Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Self-Monitoring Blood Glucose System: Market Segmentation 
FIG. 2 Global Self-Monitoring Blood Glucose System Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Self-Monitoring Blood Glucose System Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Self-Monitoring Blood Glucose System Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Self-Monitoring Blood Glucose System Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Self-Monitoring Blood Glucose System Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Self-Monitoring Blood Glucose System Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Self-Monitoring Blood Glucose System Providers, 2019
FIG. 11 Global Self-Monitoring Blood Glucose System Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Self-Monitoring Blood Glucose System Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Self-Monitoring Blood Glucose System Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Self-Monitoring Blood Glucose System Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Self-Monitoring Blood Glucose System Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Self-Monitoring Blood Glucose System Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Self-Monitoring Blood Glucose System Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Self-Monitoring Blood Glucose System Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Self-Monitoring Blood Glucose System market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
6811

4134

OUR CLIENT